Raymond James Financial’s Twist Bioscience TWST Stock Holding History

Raymond James Financial’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Sell	19,822 -2,127	-10%	-$138K	﹤0.01%	3462
2026 Q1	$1.04M	Sell	21,949 -1,010	-4%	-$45.3K	﹤0.01%	3820
2025 Q4	$728K	Sell	22,959 -18,850	-45%	-$588K	﹤0.01%	3994
2025 Q3	$1.18M	Sell	41,809 -3,685	-8%	-$112K	﹤0.01%	3578
2025 Q2	$1.67M	Sell	45,494 -110	-0.2%	-$3.8K	﹤0.01%	3227
2025 Q1	$1.79M	Sell	45,604 -2,259	-5%	-$102K	﹤0.01%	3071
2024 Q4	$2.22M	Buy	+47,863	New	+$2.16M	﹤0.01%	2888

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Raymond James Financial's TWST Position: Q2 2026 in Review

Raymond James Financial reduced its Twist Bioscience (TWST) stake by 9.7% in Q2 2026, selling an estimated $138K and leaving 19,822 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3462.

Raymond James Financial first reported a position in TWST in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.22M in Q4 2024. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Raymond James Financial held 19,822 shares of Twist Bioscience worth $2.04M as of Q2 2026.
Raymond James Financial sold 2,127 Twist Bioscience shares in Q2 2026, an estimated $138K.
Twist Bioscience made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3462 holding.
Raymond James Financial first reported a position in Twist Bioscience in Q4 2024 and has held it in 7 quarters since.
Raymond James Financial's Twist Bioscience position peaked at $2.22M in Q4 2024.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.